Table 2. The effects of miR-203 on BaF3-BCR/ABL^T315I cell cycle progression^a.

Cell type	Length of culture (h)	% of cells in indicated phase
		G1	G2	S
BaF3-BCR/ABLT315I	0	52.83	12.08	35.09
BaF3-BCR/ABLT315I-NC		52.94	13.90	33.16
BaF3-BCR/ABLT315I-miR203		53.23	13.64	33.13
BaF3-BCR/ABLT315I	2	44.43	14.58	40.99
BaF3-BCR/ABLT315I-NC		46.20	14.31	39.50
BaF3-BCR/ABLT315I-miR203		47.81	14.01	38.18
BaF3-BCR/ABLT315I	6	37.57	21.62	40.82
BaF3-BCR/ABLT315I-NC		37.44	18.29	44.27
BaF3-BCR/ABLT315I-miR203		43.56	15.59	40.85
BaF3-BCR/ABLT315I	12	26.70	23.33	49.97
BaF3-BCR/ABLT315I-NC		27.14	22.09	50.77
BaF3-BCR/ABLT315I-miR203		40.20	20.31	39.50
BaF3-BCR/ABLT315I	24	19.15	3.90	76.96
BaF3-BCR/ABLT315I-NC		22.32	2.08	75.60
BaF3-BCR/ABLT315I-miR203		31.85	4.41	63.74

^aCells were incubated for 48 h in serum-free medium to synchronize cells in the G1 phase at 0 h. After that, cells were incubated in the medium with 10% FCS and collected at 2 h, 6 h, 12 h, and 24 h. The percentages of cells in G1, G2, and S phases were evaluated by flow cytometry.